PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

New substance effectively combats multi-resistant bacteria

2013-10-30
(Press-News.org) Contact information: Rasmus Jahnsen
rasmus.jahnsen@sund.ku.dk
45-26-27-88-04
University of Copenhagen
New substance effectively combats multi-resistant bacteria MULTI-RESISTANCE: In Europe alone, more than 25,000 people die each year from infections caused by multi-resistant bacteria. Researchers from University of Copenhagen have now developed and characterized a substance that quickly and effectively kills the virulent bacteria. The substance employs a multifunctional mechanism that reduces the risk of antibiotic resistance. The findings have recently been published in the scientific journal Chemistry & Biology.

Since WWII, antibiotics have made it possible to cure lethal bacterial infections. However, in recent years the efficacy of antibiotics has been drastically reduced due to increasing bacterial resistance. Today, bacteria resistant to nearly all known antibiotics are prevalent in many parts of the world.

"We have succeeded in preparing and characterizing a very stable substance that kills multi-resistant bacteria extremely quickly and effectively. The most interesting aspect is that the bacteria are attacked using a multifunctional mechanism that drastically reduces the risk of resistance development compared with traditional antibiotics," says Rasmus Jahnsen.

Jahnsen conducted the research into the development of substances against multi-resistant bacteria at the Department of Drug Design and Pharmacology, University of Copenhagen.

The recently developed substance is called HDM-4, which stands for Host Defence Peptidomimetic 4. The findings are the result of collaboration between University of Copenhagen and the University of British Columbia in Canada.

Boosts the innate immune response

For a number of years, a group of researchers led by Associate Professor Henrik Franzyk at the Faculty of Health and Medical Sciences have worked on the optimization of a unique class of antibacterial substances. All plants, animals and humans produce the important antimicrobial peptides that form part of the innate immune system – the body's first line of defence against bacterial attack.

"The killing mechanism involves destabilising the bacterial membrane and binding onto the bacteria's DNA, which in both cases results in the death of the bacteria. We have also shown that the substance can activate the human body's own immune cells, strengthening its defence against bacteria during infection," says Rasmus Jahnsen.

Pharmaceutical industry lacks interest in antibiotics

The researchers have tested the new substance on bacteria-infected tissue and the results show that it possesses several characteristics that make it highly attractive in connection with the possible development of new antibiotics.

"It's the first step to developing a new drug. We hope that in collaboration with partners we can conduct a series of tests in the near future to show that the substance can actually combat an infection in a mammal. If we achieve the same results in animals, we will have a potential sensation on our hands," adds Rasmus Jahnsen.

Jahnsen believes the pharmaceutical industry needs to become more actively involved.

"Only a tiny fraction of the pharmaceutical research is devoted to development of new antibiotics — partly because research into cancer and chronic diseases such as diabetes and cardiovascular diseases are seen as better long-term investments. This leaves us in the extremely unfortunate situation where infectious diseases once again pose extremely serious threats to human health as the efficacy of medical drugs continues to be undermined by bacterial resistance. It is therefore important to conduct more research into new antibiotics," concludes Rasmus Jahnsen.

### Fact box: The research is the result of a collaboration between University of Copenhagen and the University of British Columbia (UBC) in Canada. Initially, the researchers at the Department of Drug Design and Pharmacology (DDP), University of Copenhagen, focused on identifying the ideal chemical structure together with an effective method for its preparation. They subsequently tested and characterised the substance at the Centre for Microbial Disease and Immunity Research (UBC), where Rasmus Jahnsen spent six months as a guest researcher in connection with his PhD project entitled "Peptidomimetics as novel antibiotics" that has been carried out in the Natural Products Research (NPR) Group at DDP (Faculty of Health and Medical Sciences) with Associate Professor Henrik Franzyk as main supervisor and Professor Niels Frimodt-Møller (SSI/Hvidovre Hospital) as co-supervisor. The PhD project constitutes a part of the strategic research centre DanCARD (Danish Centre for Antibiotic Research and Development).


ELSE PRESS RELEASES FROM THIS DATE:

Moral in the morning, but dishonest in the afternoon

2013-10-30
Moral in the morning, but dishonest in the afternoon Our ability to exhibit self-control to avoid cheating or lying is significantly reduced over the course of a day, making us more likely to be dishonest in the afternoon than in the ...

Institute explores intimate partner violence across generations

2013-10-30
Institute explores intimate partner violence across generations HUNTSVILLE, TX (10/30/13) -- Most parents who experienced intimate partner violence had children that grew to face violence in their own adult relationships, according to a study published by the Crime ...

How fat could help solve part of the diabetes problem

2013-10-29
How fat could help solve part of the diabetes problem The pancreas is a large organ that wraps around our gut, and produces the exact amount of insulin our bodies need when we eat – except when we start to develop diabetes, and insulin production ...

Did brain tumor stem cells originate from malignant neural stem cells?

2013-10-29
Did brain tumor stem cells originate from malignant neural stem cells? Although it is believed that glioma is derived from brain tumor stem cells, the source and molecular signal pathways of these cells are still unclear. The potential of neural stem cells to ...

Association between glioma susceptibility and XRCC1 Arg399Gln polymorphism

2013-10-29
Association between glioma susceptibility and XRCC1 Arg399Gln polymorphism DNA damage is an important mechanism of glioma. X-ray cross-complementing group 1 (XRCC1) is a DNA repair gene that participates in the base excision repair pathway. To date, many studies ...

A new DNA vaccine induces a Th2 immune response in Alzheimer's disease mice

2013-10-29
A new DNA vaccine induces a Th2 immune response in Alzheimer's disease mice Amyloid-beta (Aβ) active immunization in Alzheimer's disease can increase the rate of Aβ clearance, and delay cognitive dysfunction, but it is easy to induce meningoencephalitis, ...

New drug to help common bowel disease

2013-10-29
New drug to help common bowel disease An international team led by University of Adelaide researchers has identified the mechanism of pain relief of a new drug for treating Irritable Bowel Syndrome with Constipation (IBS-C), based on nonclinical ...

Human immune system shapes skin microbiome

2013-10-29
Human immune system shapes skin microbiome October 29, 2013 -- Our skin plays host to millions of beneficial and potentially disease-causing microorganisms; however, whether our immune system influences these microbial communities to prevent disease is ...

Pregnant rats exposed to obesity hormone lose birth's protective effect on breast cancer

2013-10-29
Pregnant rats exposed to obesity hormone lose birth's protective effect on breast cancer WASHINGTON — Like humans, young rats that give birth have a reduced risk of breast cancer later in life. But a new study shows that this protective effect in animals is negated ...

A potential new class of fast-acting antidepressant

2013-10-29
A potential new class of fast-acting antidepressant More than 1 in 10 Americans take antidepressants, but these medications can take weeks—and for some patients, months—before they begin to alleviate symptoms. Now, scientists from the University ...

LAST 30 PRESS RELEASES:

University of Phoenix College of Social and Behavioral Sciences leadership publishes white paper on trauma-informed education

Microbial iron mining: turning polluted soils into self-cleaning reactors

Molecular snapshots reveal how the body knows it’s too hot

Analysis finds alarming rise in severe diverticulitis among younger Americans

Mitochondria and lysosomes reprogram immune cells that dampen inflammation

Cockroach infestation linked to home allergen, endotoxin levels

New biochar-powered microbial systems offer sustainable solution for toxic pollutants

Identifying the best high-biomass sorghum hybrids based on biomass yield potential and feedstock quality affected by nitrogen fertility management under various environments

How HIV’s shape-shifting protein reveals clues for smarter drug design

Study identifies viral combinations that heighten risk of severe respiratory illnesses in infants

Aboveground rather than belowground productivity drives variability in miscanthus × giganteus net primary productivity

Making yeast more efficient 'cell factories' for producing valuable plant compounds

Aging in plain sight: What new research says the eyes reveal about aging and cardiovascular risk

Child welfare system involvement may improve diagnosis of developmental delays

Heavier electric trucks could strain New York City’s roads and bridges, study warns

From womb to world: scientists reveal how maternal stress programs infant development

Bezos Earth Fund grants $2M to UC Davis and American Heart Association to advance AI-designed foods

Data Protection is transforming humanitarian action in the digital age, new book shows

AI unlocks the microscopic world to transform future manufacturing

Virtual reality helps people understand and care about distant communities

Optica Publishing Group announces subscribe to open pilot for the Journal of the Optical Society of America B (JOSA B)

UNF partners with Korey Stringer Institute and Perry Weather to open heat exercise laboratory on campus

DNA from Napoleon’s 1812 army identifies the pathogens likely responsible for the army’s demise during their retreat from Russia

Study suggests two unsuspected pathogens struck Napoleon's army during the retreat from Russia in 1812

The 25-year incidence and progression of hearing loss in the Framingham offspring study

AI-driven nanomedicine breakthrough paves way for personalized breast cancer therapy

Fight or flight—and grow a new limb

Augmenting electroencephalogram transformer for steady-state visually evoked potential-based brain–computer interfaces

Coaches can boost athletes’ mental toughness with this leadership style

Tunable neuromorphic computing for dynamic multi-timescale sensing in motion recognition

[Press-News.org] New substance effectively combats multi-resistant bacteria